Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

C4X licenses orexin-1 receptor antagonist C4X-3256 to Indivior

March 29, 2018

Curadim licenses rights to Ube's LPA1 selective antagonist

March 29, 2018

Abide Therapeutics grants Celgene worldwide license for ABX-1772

March 29, 2018

Vifor Pharma grants Zeria license to develop and market Veltassa in Japan

March 29, 2018

Nabriva Therapeutics and Roivant Sciences enter lefamulin license agreement

March 29, 2018

Carna Biosciences enters joint research agreement with Sumitomo Dainippon Pharma

March 28, 2018

FORMA Therapeutics establishes collaboration with Arpeggio Biosciences

March 27, 2018

CBT Pharmaceuticals licenses anti-CTLA-4 monoclonal antibody from Crown Bioscience

March 23, 2018

CARB-X and Shionogi partner to develop a novel antibiotic

March 23, 2018

SemaThera signs financing and licensing deal for ST-102

March 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...